Bristol-Myers Squibb CompanyBMYNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.0%
5Y CAGR+3.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.0%/yr
vs +15.5%/yr prior
5Y CAGR
+3.0%/yr
Consistent
Acceleration
-10.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.91B | +12.0% |
| 2024 | $17.77B | +5.3% |
| 2023 | $16.89B | -1.9% |
| 2022 | $17.22B | -0.0% |
| 2021 | $17.22B | +0.1% |
| 2020 | $17.21B | +59.2% |
| 2019 | $10.81B | +11.7% |
| 2018 | $9.68B | -0.4% |
| 2017 | $9.72B | +4.3% |
| 2016 | $9.32B | - |